Know What's Happening in Healthcare
Know What's Happening in Healthcare
FDA approves KRESLADI, first CIRM‑backed gene‑editing therapy
The FDA cleared KRESLADI, a gene‑editing treatment from Rocket Pharmaceuticals for severe leukocyte adhesion deficiency‑I in children, eliminating the need for a bone‑marrow donor. It is the first product directly funded by California’s Institute for Regenerative Medicine to receive approval.
Also developing:
By the numbers: Syneron Bio raises $150M Series B
The article updates the classic six‑factor framework for medical‑device commercialization, highlighting that Technological Feasibility, Market Size, and Reimbursement Potential remain top‑ranked but now demand AI integration, digital‑health ecosystem compatibility, and early payer engagement. Regulatory pathways have shifted dramatically with the 2026 Quality Management System Regulation (QMSR) and new cybersecurity mandates, turning compliance into a pass/fail gate. Emerging considerations such as data assets, AI lifecycle management, and real‑world evidence generation are now essential for market success. A hybrid decision model combines threshold criteria with weighted strategic factors to guide innovators.
In Episode 9 of Drug Dealin, hosts Kenny and Shibu demonstrate how patients can use publicly available tools like ClinicalTrials.gov and AI language models to uncover novel treatment options, focusing on a hypothetical Parkinson’s disease case inspired by a TV...
The United States still uses an opt‑in organ donation system, meaning individuals must actively register to become donors. Behavioral‑economics research shows that default settings heavily influence decisions, and the opt‑in model creates inertia at points like DMV renewals. Countries that...
YOU(th) has secured US$4.5 million to scale its AI‑driven smartphone health‑screening platform, which evaluates over 50 digital biomarkers in under two minutes. The round was led by Callisto Health with participation from caesar., adesso Ventures, Antler, Moonstone, 1024 Ventures and notable...
Valant announced expanded AI Notes Assist, an AI‑driven documentation tool that now supports more than 100 behavioral health note templates, including SOAP, DAP, BIRP and custom formats. Integrated directly into Valant’s secure EHR, the solution generates structured notes from in‑person,...
ViVE 2026 in Los Angeles marked a decisive shift from digital ambition to operational accountability across the health ecosystem. Leaders emphasized that AI adoption now hinges on governance, measurable ROI, and clinician trust, while interoperability is being treated as core...
India’s healthcare landscape is rapidly pivoting from multi‑speciality hospitals to single‑speciality providers such as eye‑care, fertility and dialysis clinics. The shift is fueled by rising health‑insurance coverage, an ageing population and strong private‑capital appetite. While the overall market is projected...
Researchers have captured the fleeting i‑DNA structure inside living cells, showing it acts as a molecular switch for genes that drive cancer. The study demonstrates that i‑DNA formation and resolution are tightly timed during DNA replication, influencing gene expression and...
Continuous cardiac monitoring via wearable ECG devices is reshaping clinical trials and post‑market care. Recent studies show that 14‑day monitoring after cardiac surgery uncovered atrial fibrillation in 24% of patients, many of which were missed until three‑month follow‑ups. In epilepsy...
Signing bonuses remain a notable recruiting tool despite a cooling labor market, appearing in about 3% of U.S. job postings in December 2025—down from a 5.6% peak in 2022 but still above the 2019 average of 1.8%. Wage growth in...
Mark Cuban suggests treating hospitals like lean start‑ups, mirroring his Cost Plus Drugs model. He would enforce fixed, transparent margins, pay physicians above market rates, and strip away non‑essential infrastructure. Cuban also argues that AI‑driven contract automation could slash administrative...
Cara Medical announced that the U.S. FDA granted 510(k) clearance for its CARA System, a non‑invasive solution that creates patient‑specific 3‑D visualizations of the cardiac conduction system using CTA data. The platform pairs the CARA Metis™ Simulator for pre‑procedural mapping...
In 2025 the Centers for Medicare & Medicaid Services launched a voluntary Premium Stabilization Demonstration for Medicare Part D standalone drug plans to curb steep premium hikes and protect enrollment. GAO analysis showed that without the program, average premiums would have...
Digital imaging, especially 3D scanning and advanced radiography, is reshaping orthodontic diagnostics and treatment planning. These tools generate highly detailed virtual models and clearer X‑ray images while exposing patients to less radiation. The technology enables personalized treatment plans, real‑time monitoring,...
The post‑holiday period often reveals hidden cardiovascular strain from excess calories, alcohol, and disrupted sleep. These habits can raise blood pressure, cholesterol, and glucose, creating a short‑term risk window. Men face higher risk due to binge‑drinking patterns and delayed preventive...
![[Comment] Oral GLP-1 Receptor Agonists: Competition for Efficacy and Tolerability](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/ce10e510d7294b419a4a07dfad918da4.webp)
Oral GLP-1 receptor agonists have moved from injectable peptides to a tablet form, highlighted by oral semaglutide combined with the absorption enhancer SNAC. The formulation requires patients to fast overnight, take the dose with a small amount of water, and...
GlaxoSmithKline announced that China’s National Medical Products Administration has accepted the New Drug Application for linerixibat and placed it under priority review for treating cholestatic pruritus in primary biliary cholangitis (PBC). The filing is backed by the Phase III GLISTEN trial,...
A new study shows that maternal obesity dramatically shortens the lifespan of mouse offspring, even when the pups are switched to a healthy diet after weaning. The reduction in longevity is linked to early‑life epigenetic programming that triggers widespread organ...
Chronic liver disease in the UK is often identified only after emergency admission, with more than a third of such patients dying within a year. Stigma and competing primary‑care priorities leave up to 80 % of MASH cases undiagnosed, driving rising...
Buzz Health President Joseph Kleiman says TrumpRx is advancing drug‑price transparency by giving consumers early visibility into prescription costs. He notes that real‑time pricing can help patients compare options but also warns that prices are dynamic and may change before...
Otsuka America became the first major pharmaceutical company to back psychedelic‑inspired medicines in 2020 through a partnership with COMPASS Pathways, and deepened that commitment by acquiring Mindset in 2023. The company is applying its long‑standing CNS expertise to develop serotonergic...
Merck Animal Health announced that the U.S. FDA has approved Numelvi (atinvicitinib) for controlling pruritus linked to allergic dermatitis in dogs six months and older, with commercial availability slated for spring 2026. Numelvi is a second‑generation JAK inhibitor that demonstrates...
Researchers at the University of Edinburgh have created a luminescent reporter that detects granzyme A activity in stool samples, offering a rapid, non‑invasive marker of gut inflammation. In a trial of 150 specimens, the new assay combined with standard faecal calprotectin...
The FDA has rejected Regenxbio’s gene therapy for mucopolysaccharidosis type 2, citing a need for additional data that could postpone approval by years. This decision adds to at least four other recent rejections of cell or gene therapies targeting deadly rare...
Mahzi Therapeutics has administered the first dose of its investigational gene therapy MZ-1866 in the Phase I/II UNITE study for Pitt‑Hopkins syndrome. The open‑label, multicentre trial will enroll roughly 12 genetically confirmed patients across sites in Spain, Israel and the...
Women’s HealthX (WoHX) will convene 750 pharma, biotech, hospital, insurer, startup and government leaders in Boston on December 3‑4, 2026. The two‑day summit aims to close the sex‑difference data gap by showcasing evidence‑based technologies, AI tools and digital therapeutics across the...
The Trump administration launched TrumpRx, a website aggregating manufacturer discounts on 43 brand‑name drugs and touting presidential credit for lower patient costs. Early analysis shows that 20 of the listed products already have cheaper generic versions, and the portal deliberately...
A meaningful share: AuthorsReading posted an editorial review of The Doctor’s Future. They spotlight the book’s focus on the real-world questions behind AI/robotics in healthcare—privacy, accountability, ethics, patient trust, and how clinicians can adapt their roles with clarity (supported by the...
Sword Intelligence has launched its AI‑driven care‑operations platform in the UK, targeting NHS waiting‑list pressures. The solution automates triage, coordination, outreach and scheduling, freeing clinical capacity without major staffing or infrastructure upgrades. Simultaneously, the company is building one of Europe’s...
Researchers investigated how hydrothermal processing—both classic autoclave and microwave irradiation—affects the transverse relaxivity (r₂) of DyF₃ nanoparticle colloids. Using ¹H NMR at magnetic fields of 0.6 T, 3.65 T and 9.4 T, they found that autoclave‑treated samples exhibit the highest r₂ values, outperforming...
San Francisco and South San Francisco remain biotech hubs, employing over 113,700 workers according to a Cushman & Wakefield report. Although BioSpace job postings fell sharply in January, listings are now climbing, with ten companies actively hiring. Companies such as AbbVie, Amgen, Eli Lilly and Ideaya...
argenx announced topline Phase III ADAPT OCULUS data for Vyvgart (efgartigimod alfa + hyaluronidase‑qvfc) in adults with ocular myasthenia gravis. The trial met its primary endpoint, delivering a 4.04‑point improvement in Myasthenia Impairment Index PRO ocular scores versus 1.99 points for placebo at...
Whiddon, a leading residential aged‑care provider in NSW and southeast Queensland, has deployed Telstra Health’s centralised care‑planning platform across its 24 homes. The system enables real‑time, point‑of‑care documentation, family portals and mobile workflows, replacing legacy paper‑based processes. By achieving data...
IEEE has a very technical overview of ingestible electronics and tomorrow's smart pills that could one day deliver drugs and take biopsies. To "take actions based on its findings" is a bit too far-fetched for now. What can these technologies definitely...
We're making headway for off the shelf preventive cancer vaccines in people with hereditary forms of cancer, e.g. Lynch syndrome https://t.co/F3LqKS46BQ
The UK Medicines and Healthcare products Regulatory Agency (MHRA) is urging that AI innovation in healthcare be paired with robust regulation to safeguard patient safety and equity. Richard Stubbs, CEO of Health Innovation Yorkshire and Humber, highlighted the need for...
AI is entering public health infrastructures, connecting epidemiology, clinical data, and research into shared intelligence. When models flag outbreaks early and automate routine tasks, health systems allocate resources with precision and reduce delays. Microblog @antgrasso https://t.co/nuhbxsiFX3
Always fun to look over @JohnCendpts annual list of the top 100 most active VCs in biotech for the past year Top 5, by # of rounds: 1. OrbiMed 2. RA Capital 3. GV 4. General Catalyst 5. Catalio Full list & analysis is live...
Governor Josh Shapiro convened a crisis response after Pennsylvania reported roughly 7.6 million birds infected with avian influenza, prompting a coordinated effort with the USDA and veterinary specialists to contain the outbreak and explore vaccine options. Simultaneously, H5N1 cases have emerged...
$RVMD was collaborating with $TNGX in PRMT5, but now it's working with $BMY (remember that ex MRTX project?). Via @ByMadeleineA @ApexOnco -> https://t.co/mGZjKOiB7p (And $AMGN still dose optimising.)
I enjoyed working with an all-star team – the great @LisaRotenstein @UCSF and @DBatesSafety of @BrighamWomens – on this paper describing how to measure return on investment (ROI) for clinician-facing AI tools. @JAMAInternalMed https://t.co/uvhb1qI7mG
Sigma Healthcare reported double‑digit growth in its first‑half fiscal results, driven by the Chemist Warehouse network. Revenue rose 15% to $5.5 billion, normalised EBIT increased 18.7% to $582.9 million, and NPAT grew 19.2% to $392 million. Chemist Warehouse sales jumped 17.2% to $5.1 billion,...
The Fifth Circuit rejected the DEA’s long‑standing reading of the pharmacist’s “corresponding responsibility” and “usual course of professional practice” regulations, ruling that liability requires proof a prescription was invalid when issued and that the pharmacist actually knew it was invalid....
An interdisciplinary team at University Health Network (UHN) received the Mission of Excellence Team Inventor of the Year Award for creating H.A.L.O., a remote patient monitoring system. Launched as a company in early 2025, H.A.L.O. now operates across 50 inpatient...
The Schroeder Ambulatory Centre (SAC), a $300 million private non‑profit facility in Richmond Hill, Ontario, has opened its doors with operating rooms, MRI, CT and GI endoscopy capabilities while awaiting full accreditation. It secured $14 million from the provincial government to deliver...
A congressional hearing highlighted that current Medicare GME funding formulas leave rural hospitals like Phelps Health struggling to bridge the $5‑$7 million gap between planning grants and accreditation costs. Hospital leaders argue that outdated per‑resident caps and rigid grant structures create...
Trillium Health Partners has launched a clinical AI application that automatically detects intracranial hemorrhage on head CT scans, flagging urgent cases in real time. The tool, sourced through Sectra Amplifier Services, also identifies midline shift, mass effect and skull fractures,...
OPKO Health reported a $369 million cash position for Q4 2025, driven by asset sales, BARDA funding and partnership payments. The company repurchased 34.6 million shares for $47 million and allocated $109 million to stock and convertible note buybacks. Diagnostics revenue dropped to $71.1 million, but...
Anika Therapeutics reported total revenue of $27.8 million for the quarter, a 6% year‑over‑year decline driven primarily by lower pricing in its OEM osteoarthritis pain‑management channel. Commercial channel revenue rose 22% to $12 million, powered by a 25% surge in...
Biodesix reported fourth‑quarter 2021 revenue of $7.2 million and total 2021 revenue of $54.5 million, a 20% year‑over‑year increase driven by strong growth in its core lung‑diagnostic portfolio. Core lung‑test sales jumped 49% to $18.7 million, while COVID‑19 testing revenue collapsed, lifting the...
